bio CDMO

South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

Johnson & Johnson, a global pharmaceutical giant, showed more interest in South Korean bio startups with competitive innovation despite the rece...

SK Group, South Korea’s energy-to-semiconductor conglomerate, is set to invest in a local renewable energy ingredient provider for stable proc...

LG Chem Ltd. and GS Caltex Corp. are accelerating their efforts in the eco-friendly bio-material business involving 3-hydroxypropionic acid (3HP). 3...

South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...

South Korean food and bio giant CJ CheilJedang Corp. on Monday said its Chief Technology Officer Hwang Yun-il, CJ CheilJedang BIO executive Yoon Seo...

Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...

South Korea's Lotte Chemical Corp. has launched its eco-friendly material brand, "Ecoseed." The company announced on Tuesday that it unveiled the Ec...

South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...

South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...

Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...

The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...

Artificial intelligence, bio and clean tech are in their early stages of development for LG Group, but they should lead the South Korean conglomerat...

South Korea’s DongKoo Bio & Pharma Co. on Tuesday said it signed a memorandum of understanding with the Philippine healthcare group Adizat...

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...

South Korea’s largest investment conference will be held in Seoul Sept. 11-15 with around 100 chief executives from global financial services ...

New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured 12 global pharm...

South Korean bio-health company HK inno.N Corporation's new drug for gastroesophageal reflux disease (GERD) K-CAB has been officially launched in In...

SK Group, South Korea’s second-largest conglomerate, is set to purchase the entire stake in a US bio joint venture held by its partner, as the...

Korean Air Lines Co. announced on Thursday that it will start operating bio-jet fuel flights in partnership with GS Caltex Corp., marking the first ...

South Korea’s LG Group seeks new partnerships with global ventures to strengthen its new growth engines, such as batteries, biopharmaceuticals...

South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...

Daesang Corp., South Korean manufacturer of food and pharmaceutical ingredients, announced on Wednesday that it has developed a new eco-friendly mat...

Samsung Biologics Co., the world’s No. 1 contract drugmaker, announced a groundbreaking strategic partnership with Pfizer on Thursday, marking...

BOSTON – Samsung Biologics Co., the world’s No. 1 contract drugmaker, plans to more than double its total annual production capacity to ...

More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...

Koo Kwang-mo, chairman of South Korea’s fourth-largest conglomerate LG, is seeking new growth drivers by hosting strategy meetings groupwide.L...